PCN33 COST-UTILITY ANALYSIS OF CHEMOTHERAPY IN ADVANCED OR RECURRENT GASTRIC CANCER- ORAL FLUOROPYRIMIDINETS-I VERSUS CONVENTIONAL INTRAVENOUS CHEMOTHERAPY
Nov 1, 2005, 00:00 AM
10.1016/S1098-3015(10)67271-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)67271-3/fulltext
Section Title :
Section Order :
501
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)67271-3&doi=10.1016/S1098-3015(10)67271-3